Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-06-18
1999-08-10
Degen, Nancy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 4351723, 4353201, 536 231, 536 241, 536 245, C07H 2104, A61K 4800
Patent
active
059359374
ABSTRACT:
Compositions and methods for the treatment of malignant cells are disclosed, particularly antisense nucleic acid molecules and their use in inhibiting the deregulated cellular proliferation of tumor cells, while not adversely affecting the growth of normal cells.
REFERENCES:
patent: 5585479 (1996-12-01), Hoke et al.
M. Smith et al., Cancer Gene Therapy, 2(3): 207-212 (1995).
M. Crescenzi et al., Proc. Natl. Acad. Sci. USA, 85: 4869-4873 (1988).
H. Dorai et al., Nucleic Acids Research, 17(15): 6412 (1989).
M. Seto et al., The EMBO Journal, 7(1): 123-131 (1988).
M. Cleary et al., Cell, 47: 19-28 (1986).
F. Keith et al., Leukemia, 9: 131-138 (1995).
S. Kitada et al., Antisense Research and Development, 4: 71-79 (1994).
Stull et al "Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects" Pharmaceutical Research vol. 12(4)485-483 1995.
Degen Nancy
Fox Chase Cancer Center
McGarry Sean
LandOfFree
Compositions and methods for inducing apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inducing apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inducing apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120256